These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34077513)

  • 1. Atrial fibrillation burden during the coronavirus disease 2019 pandemic.
    O'Shea CJ; Middeldorp ME; Thomas G; Harper C; Elliott AD; Ray N; Campbell K; Lau DH; Sanders P
    Europace; 2021 Sep; 23(9):1493-1501. PubMed ID: 34077513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admission rates and care pathways in patients with atrial fibrillation during the COVID-19 pandemic-insights from the German-wide Helios hospital network.
    Ueberham L; König S; Pellissier V; Hohenstein S; Meier-Hellmann A; Kuhlen R; Hindricks G; Bollmann A
    Eur Heart J Qual Care Clin Outcomes; 2021 May; 7(3):257-264. PubMed ID: 33729489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic.
    O'Shea CJ; Thomas G; Middeldorp ME; Harper C; Elliott AD; Ray N; Lau DH; Campbell K; Sanders P
    Eur Heart J; 2021 Feb; 42(5):520-528. PubMed ID: 33321517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of atrial high-rate episodes on the risk of future stroke.
    Nakano M; Kondo Y; Nakano M; Kajiyama T; Hayashi T; Ito R; Takahira H; Kobayashi Y
    J Cardiol; 2019 Aug; 74(2):144-149. PubMed ID: 30728105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Association Between Atrial Fibrillation Burden in Cardiac Implantable Electronic Devices and the Risk of Heart Failure Hospitalization.
    Ahluwalia N; Koehler J; Sarkar S; Vasudevan N; Majumder S; Landman SR; Schilling RJ
    Circ Arrhythm Electrophysiol; 2024 Aug; 17(8):e012842. PubMed ID: 38939945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
    Ricci RP; Vaccari D; Morichelli L; Zanotto G; Calò L; D'Onofrio A; Curnis A; Pisanò EC; Nangah R; Brieda M; Calzolari V; Melissano D; Rovai N; Gargaro A
    Int J Cardiol; 2016 Sep; 219():251-6. PubMed ID: 27340918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of COVID-19 on Admissions and Management of Patients with Atrial Fibrillation Episodes in the Emergency Department.
    Bilaszewski Ł; Timler W; Budrewicz K; Marczak M; Kozłowski R; Wizowska J; Timler M; Jagielski D; Dudek M; Rasmus P; Zyśko D; Timler D
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34199795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device-detected atrial fibrillation in a large remote-monitored cohort: implications for anticoagulation and need for new pathways of service delivery.
    O'Shea CJ; Brooks AG; Middeldorp ME; Harper C; Hendriks JM; Russo AM; Freeman JV; Gopinathannair R; Varma N; Deering TF; Campbell K; Sanders P
    J Interv Card Electrophysiol; 2023 Oct; 66(7):1659-1668. PubMed ID: 36735111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes.
    Swiryn S; Orlov MV; Benditt DG; DiMarco JP; Lloyd-Jones DM; Karst E; Qu F; Slawsky MT; Turkel M; Waldo AL;
    Circulation; 2016 Oct; 134(16):1130-1140. PubMed ID: 27754946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
    Di Cori A; Lilli A; Zucchelli G; Zaca V
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation.
    Imberti JF; Bonini N; Tosetti A; Mei DA; Gerra L; Malavasi VL; Mazza A; Lip GYH; Boriani G
    Biology (Basel); 2022 Mar; 11(3):. PubMed ID: 35336817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Doundoulakis I; Gavriilaki M; Tsiachris D; Arsenos P; Antoniou CK; Dimou S; Soulaidopoulos S; Farmakis I; Akrivos E; Stoiloudis P; Notas K; Kimiskidis VK; Giannakoulas G; Paraskevaidis S; Gatzoulis KA; Tsioufis K
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):951-958. PubMed ID: 34089429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices.
    Miyazawa K; Kondo Y; Nakano M; Esteve-Pastor MA; Rivera-Caravaca JM; Senoo K; Kobayashi Y; Lip GYH
    Eur J Intern Med; 2018 Jun; 52():54-59. PubMed ID: 29490874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).
    Boriani G; Glotzer TV; Santini M; West TM; De Melis M; Sepsi M; Gasparini M; Lewalter T; Camm JA; Singer DE
    Eur Heart J; 2014 Feb; 35(8):508-16. PubMed ID: 24334432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden.
    Boriani G; Lip GYH; Ricci RP; Proclemer A; Landolina M; Lunati M; Padeletti L; Zanotto G; Molon G; Biffi M; Rordorf R; Quartieri F; Gasparini M
    Europace; 2017 Nov; 19(11):1767-1775. PubMed ID: 28031277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices.
    Piccini JP; Passman R; Turakhia M; Connolly AT; Nabutovsky Y; Varma N
    Europace; 2019 Mar; 21(3):404-413. PubMed ID: 30462208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.
    Benezet-Mazuecos J; Rubio JM; Cortés M; Iglesias JA; Calle S; de la Vieja JJ; Quiñones MA; Sanchez-Borque P; de la Cruz E; Espejo A; Farré J
    Europace; 2015 Mar; 17(3):364-9. PubMed ID: 25336664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.
    Waks JW; Passman RS; Matos J; Reynolds M; Thosani A; Mela T; Pederson D; Glotzer TV; Zimetbaum P
    Heart Rhythm; 2018 Nov; 15(11):1601-1607. PubMed ID: 29981863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient initiation of dofetilide: insights from the complexities of atrial fibrillation management during the COVID-19 lockdown.
    Mascarenhas DAN; Mudumbi PC; Kantharia BK
    J Interv Card Electrophysiol; 2022 Jan; 63(1):21-28. PubMed ID: 33484394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Device-Detected Atrial Fibrillation Before and After Hospitalisation for Noncardiac Surgery or Medical Illness: Insights From ASSERT.
    McIntyre WF; Wang J; Benz AP; Belley-Côté EP; Conen D; Devereaux PJ; Wong JA; Hohnloser SH; Capucci A; Lau CP; Gold MR; Israel CW; Whitlock RP; Connolly SJ; Healey JS
    Can J Cardiol; 2021 May; 37(5):803-809. PubMed ID: 33271225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.